BioHealth News
Beyond the Breakthrough: Overcoming Georgetown’s spinout challenge
Being a university in Washington DC poses interesting challenges, but Georgetown University's Tatiana Litvin-Vechnyak is determined to turn them into opportunities. Weirdly, being located…
Read More
GSK completes acquisition of Aiolos Bio
GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of Aiolos Bio (Aiolos), a clinical-stage biopharmaceutical company focused on addressing the…
Read More
Lab Space Available at Johns Hopkins Science & Technology Park
Attention life sciences companies seeking lab space in Baltimore: Starting June 1st, a fully built-out lab/office space will be available at the Science &…
Read More
AstraZeneca Completes Acquisition of Gracell Biotechnologies
AstraZeneca today announced the successful completion of the acquisition of Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL), a global clinical-stage biopharmaceutical company developing innovative cell therapies for…
Read More
LABIOTECH: Biotechs in the US Capital: seven key players based in Washington DC
Washington DC: The heart of the BioHealth Capital Region The BioHealth Capital Region (BHCR) encompasses Maryland, Virginia, and Washington D.C., and more than 1,800 life science…
Read More
BIO comments on NIST proposal to use march-in rights for price controls
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process…
Read More
Biden-Harris Administration’s ARPA-H commits $100 million to accelerate women’s health research
First Lady Jill Biden announces funding as first major deliverable from new White House Initiative on Women’s Health Research As the first major deliverable…
Read More
TEDCO Generates $2.7 Billion in Economic Benefits for Maryland’s Ecosystem in 2023, According to Independent Study
COLUMBIA, Md. (February 21, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced the findings of an independent economic impact study detailing the contributions of…
Read More
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global company providing solutions that address public health threats and delivering life-extending products to…
Read More
Fierce Biotech: NIH to invest another $515M over 4 years for long COVID research
The National Institutes of Health is investing $515 million more into long COVID research efforts, three years after launching the initiative with $1.15 billion. The…
Read More
WBJ: New CEO at Children’s National lays out her vision
By Sara Gilgore – Staff Reporter, Washington Business Journal - Feb 15, 2024 - It was her mother’s 86th birthday when Michelle Riley-Brown received a call that…
Read More
Children’s National performs first ever HIFU procedure on patient with cerebral palsy
In January, a team of multidisciplinary doctors performed the first case in the world of using bilateral high intensity focused ultrasound (HIFU) pallidotomy on Jesus, a…
Read More
Waisman Biomanufacturing and RoosterBio Announce Collaboration for GMP Manufacturing of Cell and Exosome Therapies
FREDERICK, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- Waisman Biomanufacturing, a leading contract development and manufacturing organization (CDMO) which is strategically part of the University of Wisconsin Madison,…
Read More
Career Opportunity with BHI: Life Sciences Business Strategist
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). We…
Read More
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of an offering of 3,875,000…
Read More